Prevention of ischemic stroke

被引:4
|
作者
Jesse Weinberger
机构
[1] The Mount Sinai School of Medicine,Department of Neurology
关键词
Warfarin; Ischemic Stroke; Clopidogrel; Transient Ischemic Attack; Ticlopidine;
D O I
10.1007/s11936-002-0019-z
中图分类号
学科分类号
摘要
The primary risk factors for stroke are known, and attention to primary care of these disorders should reduce the incidence of stroke significantly. Control of hypertension, diabetes, and hyperlipidemia have all been shown to reduce the rate of stroke. Identification of potential cardioembolic sources of stroke, particularly atrial fibrillation, can prevent stroke with appropriate application of anticoagulation. Duplex Doppler B-mode sonography can establish the extent of carotid artery disease in patients with cervical bruit or risk factors for atherosclerosis, and indicate which conditions should be managed medically or surgically. Patients with a history suggestive of transient ischemic attacks can also be screened noninvasively with duplex sonography to determine if they have a critical carotid stenosis and require carotid endarterectomy. New advances in platelet antiaggregant therapy with ticlopidine, clopidogrel, and the combination of aspirin with dipyridamole have also reduced the rate of stroke to a greater degree than standard treatment with aspirin. The incidence of this devastating illness could possibly be reduced by 50% with attentive primary care management. The cardiologist is often involved in the treatment of patients at risk for stroke, and is in an ideal position to provide this care.
引用
收藏
页码:393 / 403
页数:10
相关论文
共 50 条
  • [21] Secondary stroke prevention after TIA or ischemic stroke
    Diener, Hans Christoph
    Nickenig, Georg
    HERZ, 2021, 46 (03) : 293 - 302
  • [22] Aspirin and Clopidogrel for Prevention of Ischemic Stroke
    Ruth M. Thomson
    David C. Anderson
    Current Neurology and Neuroscience Reports, 2013, 13
  • [23] Secondary Prevention after Ischemic Stroke
    Zhang, Haifeng
    Messerli, Franz H.
    Staessen, Jan A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (07): : 675 - 675
  • [24] Statins for the secondary prevention of ischemic stroke
    Cantu, Carlos
    Villarreal, Jorge
    Barinagarrementeria, Fernando
    Luis Ruiz-Sandoval, Jose
    Arauz, Antonio
    Leyva, Adolfo
    Murillo, Luis
    Antonio Fernandez-Vera, Jose
    Enrique Amaya, Luis
    Venegas, Andres
    Merino, Jose G.
    Romano, Jose
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2010, 62 (02): : 162 - 169
  • [25] ANTIPLATELET THERAPY IN THE PREVENTION OF ISCHEMIC STROKE
    VERRY, M
    PANAK, E
    CAZENAVE, JP
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1994, 36 (03): : 213 - 228
  • [26] Primary and Secondary Prevention of Ischemic Stroke
    Paciaroni, Maurizio
    Bogousslavsky, Julien
    EUROPEAN NEUROLOGY, 2010, 63 (05) : 267 - 278
  • [27] Antithrombotic treatment in the prevention of ischemic stroke
    Emre, Ufuk
    Rantanen, Kirsi
    Tatlisumak, Turgut
    CURRENT DRUG TARGETS, 2007, 8 (07) : 817 - 823
  • [28] Usefulness of anticoagulants in the prevention of ischemic stroke
    Rubio, F
    Jato, M
    CEREBROVASCULAR DISEASES, 2004, 17 : 70 - 73
  • [29] Antiplatelet Drugs for Ischemic Stroke Prevention
    Leys, Didier
    Balucani, Clotilde
    Cordonnier, Charlotte
    CEREBROVASCULAR DISEASES, 2009, 27 : 120 - 125
  • [30] Antithrombotic drugs in the prevention of ischemic stroke
    Bousser, MG
    JOURNAL DES MALADIES VASCULAIRES, 2005, 30 (05) : 267 - 279